ProShares UltraShort NASDAQ Biotechnology
11 hedge funds and large institutions have $5.61M invested in ProShares UltraShort NASDAQ Biotechnology in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.25%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
4
Reduced
2
Closed
1
Calls
$214K
Puts
–
Net Calls
+$214K
Net Calls Change
-$33K
Top Buyers
Top Sellers
1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$247K |
2 |
HF
2
HRT Financial
New York
|
$0 |
3 |
3
Jane Street
New York
|
$285K |